What changed
$STE — ADD 📊
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally.
🎯 Q1 FY26 | Rev $2B | EPS $2.83 vs $2.85 🔴
💡 Consensus expected $2.85 EPS; actual $2.83 ($0.02 miss) due to transitory currency and supply chain pressures. Market may overemphasize the miss while ignoring reaffirmed annual guidance and robust free cash flow of $850M.
📉 Reward/Risk: 4.0:1
🏢 Business Quality: 8/10 - Leading global infection prevention franchise with recurring revenue, high switching costs, and essential healthcare demand.
📊 Valuation: fair - Current P/E 26.1x, in line with historical median (50th percentile). FCF yield ~0.85% appears low but may reflect market cap data discrepancy;...
📊 Our read: ADD. Full analysis →
https://stockduty.xyz/s/STE0619
Also in play: $DELL $HPE $SMCI $NTAP $IBM $NVDA
Why it matters
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally.